IFNA2 and COVID-19: Thus in Wuxi, China zero mortality was also observed in 55 COVID-19 patients, including 8 with a severe form of the disease, using a strategy including IFN-α-2b nebulization (Jiang X. et al., 2020), while in Wuhan, China a retrospective study performed in four different hospitals (including Tongji) found an independent association between IFN-α-2b inhalation and survival (3.45 [95% CI 1.96–0.51 5.88], p < 0.001) (Mei et al., 2020).